HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a Santa Clara, California-based medical technology company (incorporated 2015, IPO November 2021) developing and commercializing electrocardiogram solutions for detecting and monitoring cardiac disease outside the healthcare facility. Its HeartBeam System is a cable-free, ambulatory 12-lead ECG that captures the heart's electrical signals in three dimensions via a credit-card-sized recording device paired with a patient app, physician portal, and cloud-based algorithms, enabling advanced arrhythmia assessment. The company completed enrollment of 134 patients in its ALIGN-ACS pilot study ahead of schedule in Q2 2026 (full results expected at TCT 2026), progressed a 510(k) pre-submission for a 12-lead ECG extended-wear patch, and began an initial commercial launch while extending its cash runway into 2027.